Source:http://linkedlifedata.com/resource/pubmed/id/14564516
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2003-12-11
|
| pubmed:abstractText |
Carboplatin hypersensitivity is an increasingly recognized toxicity in individuals receiving >6 cumulative courses of this important antineoplastic agent. We wished to determine if a novel multi-pronged approach to re-treating patients with a high risk for this potentially serious side effect could permit the safe delivery of this class of cytotoxic drugs.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0171-5216
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
130
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
25-8
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:14564516-Antineoplastic Agents,
pubmed-meshheading:14564516-Carboplatin,
pubmed-meshheading:14564516-Cisplatin,
pubmed-meshheading:14564516-Desensitization, Immunologic,
pubmed-meshheading:14564516-Drug Hypersensitivity,
pubmed-meshheading:14564516-Female,
pubmed-meshheading:14564516-Humans,
pubmed-meshheading:14564516-Middle Aged,
pubmed-meshheading:14564516-Ovarian Neoplasms,
pubmed-meshheading:14564516-Treatment Outcome
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions.
|
| pubmed:affiliation |
Department of Hematology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. markmam@ccf.org
|
| pubmed:publicationType |
Journal Article
|